Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1.74	71.26	70.04
Graham Fair Price	1279.02	2.67	0.19
PEG	-100.00	< 0.005	49.16
Price/Book	-12.98	2.02	2.32
Price/Cash Flow	187.97	-53.35	18.53
Prices/Earnings	-99.52	23.72	-4964.87
Price/Sales	0.04	5.63	5.62
Price/FCF	187.97	-53.35	18.53
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	16.51	0.16	0.14
Operating Margin	107.79	0.06	0.03
ROA	18190.39	< 0.005	< 0.005
ROE	< 0.005	0.02	18113.98
ROIC	< 0.005	0.01	167.78
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.43	< 0.005	15259.20
Dividends QOQ	28.28	-0.98	-96.54
EBIT QOQ	0.02	0.85	3930.75
EPS QOQ	-1.01	206.00	20295.53
FCF QOQ	2.68	-1.31	-51.16
Revenue QOQ	0.20	-0.11	-43.19
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	72.10	75.99	5.39
Days Sales Outstanding (DSO)	81.99	116.04	41.53
Inventory Turnover	1.25	1.18	-5.11
Debt/Capitalization	0.43	0.30	-31.00
Quick Ratio	1.03	1.08	4.38
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.77	3.85	2.18
Cash	3.19	3.09	-3.30
Capex	-0.09	-0.08	19.69
Free Cash Flow	0.47	-0.15	-69.12
Revenue	1.56	1.38	-11.13
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.27	1.30	1.80
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.72	-16.54	-2188.89
Naive Interpretation	Member

06 - Financial Health · Weak

Rating